Literature DB >> 8977855

Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis.

A Slater1, L A Smallman, A B Drake-Lee.   

Abstract

The aim of the study was to compare the numbers and distribution of mast cells in the nasal mucosa of perennial allergic rhinitis (PAR) patients and controls, as demonstrated by different staining methods for light microscopy. Biopsies of inferior turbinate mucosa were taken from 10 patients with PAR and 10 patients undergoing septoplasty or septorhinoplasty (control group). Sections for light microscopy were stained with azure A. chloroacetate esterase and an ABC immunohistochemical technique using antibody to tryptase. Three times more mast cells were found in the epithelium of PAR patients compared to controls using the immunohistochemical technique (p = 0.0074). This method demonstrated considerably more mast cells than the other stains. The increase in epithelial mast cells is consistent with the migration of mast cells seen in seasonal allergic rhinitis, and this may be important in the phenomenon of nasal priming seen after repeated antigen exposure.

Entities:  

Mesh:

Year:  1996        PMID: 8977855     DOI: 10.1017/s0022215100135388

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  A selective antagonist of histamine H₄ receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1.

Authors:  T Somma; L Cinci; G Formicola; A Pini; R Thurmond; M Ennis; D Bani; E Masini
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 2.  The new biology of histamine receptors.

Authors:  Jing-Feng Huang; Robin L Thurmond
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

3.  In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties.

Authors:  M I Strakhova; C A Cuff; A M Manelli; T L Carr; D G Witte; J L Baranowski; T A Vortherms; T R Miller; L Rundell; M J McPherson; R M Adair; A A Brito; B M Bettencourt; B B Yao; J M Wetter; K C Marsh; H Liu; M D Cowart; J D Brioni; T A Esbenshade
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

Authors:  S Rico; Rm Antonijoan; Mj Barbanoj
Journal:  J Asthma Allergy       Date:  2009-08-31

5.  Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors.

Authors:  Charlotte L Weller; Sarah J Collington; Jeremy K Brown; Hugh R P Miller; Adam Al-Kashi; Peter Clark; Peter J Jose; Adele Hartnell; Timothy J Williams
Journal:  J Exp Med       Date:  2005-06-13       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.